ALPS Medical Breakthroughs ETF SBIO · ETF Open ALPS Medical Breakthroughs ETF in new tab
Weights
Sector Weights
Country Weights
United States
Canada
Netherlands
United Kingdom
Belgium
China
Germany
Singapore
Switzerland
ALPS Medical Breakthroughs ETF Analysis (SBIO)
Investment Objective: ALPS Medical Breakthroughs ETF is an investment vehicle focused on the Financial Services sector in US. It is currently trading at 53.38 USD.
Portfolio Composition:
The fund is heavily weighted towards
the Healthcare sector (100%)
and markets in
United States (89%),
Canada (3%),
Netherlands (2%)
.
For a full breakdown of all holdings, see the "Weights" card above.
Income: This is a distributing fund with a current yield of 2.36%.
Investor FAQ
Does ALPS Medical Breakthroughs ETF pay a dividend?
Yes, it pays an annual dividend of 1.26 USD (2.36% yield).
What asset class is ALPS Medical Breakthroughs ETF?
ALPS Medical Breakthroughs ETF is classified as a ETF. You can compare it against its peer in the "Related Symbols" list.
Fund Strategy
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
| Year | Total Dividends |
|---|---|
| ▸2024 |
1.17 USD
|
| Dec. 26, 2024 | 1.1740 |
| ▸2023 |
0.07 USD
|
| Dec. 27, 2023 | 0.0710 |
| ▸2019 |
0.02 USD
|
| Dec. 27, 2019 | 0.0160 |
| ▸2018 |
0.78 USD
|
| Dec. 27, 2018 | 0.7840 |
| ▸2017 |
0.58 USD
|
| Dec. 28, 2017 | 0.5790 |
Community Discussion